journal article·2009-07Open access

Perspectives on: Supercritical Fluid Technology for 3D Tissue Engineering Scaffold Applications

Ana Rita C. Duarte, João F. Mano, Rui L. Reis

Abstract

Supercritical fluid technology has proven to be useful for many pharmaceutical applications and is now emerging as an alternative to conventional processes for the preparation of 3D structures and injectable particles suitable to be used in regenerative medicine. A current overview of the basic principles underlying supercritical fluid technology, the state of the art and future potential of this technology are presented.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Polymer Foaming and Composites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

3B's Research Group - Biomaterials, Biodegradables and Biomimetics, Department of Polymer Engineering, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark Zona Industrial da Gandra, S. Cláudio do Barco 4806-909 Caldas das Taipas, Guimarães, Portugal, IBB - Institute for Biotechnology and Bioengineering PT Associated Laboratory (Laboratório Associado), Portugal

3B's Research Group - Biomaterials, Biodegradables and Biomimetics, Department of Polymer Engineering, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark Zona Industrial da Gandra, S. Cláudio do Barco 4806-909 Caldas das Taipas, Guimarães, Portugal, , IBB - Institute for Biotechnology and Bioengineering PT Associated Laboratory (Laboratório Associado), Portugal

References (56)

Show source-provided references
1. 10.1016/S1359-0286(02)00075-X10.1016/S1359-0286(02)00075-X ↗
2. 10.1016/S1359-0286(02)00077-310.1016/S1359-0286(02)00077-3 ↗
3. 10.1163/15685620174448910.1163/156856201744489 ↗
4. Pasquali, I. · J. Pharm. Sci. · 2006 · 27 · 299
6. CPMP/ICH/283/95, ICH Guideline Q3C, Impurities Residual Solvents, 1997. 7. Moroni, L., de Wijn, J.R. and van Blitterswijk, C.A. (2008). Integrating Novel Technologies to Fabricate Smart Scaffolds, J. Biomater. Sci. Polym. Ed., 19(5): 543-572.10.1163/156856208784089571 ↗
7. Fu, Q. · Mat. · 2008 · 3 · 02500
8. 10.1007/s10856-007-3214-310.1007/s10856-007-3214-3 ↗
9. 10.1021/bm060531110.1021/bm0605311 ↗
10. 10.1007/s10856-006-0680-y10.1007/s10856-006-0680-y ↗
11. Gomes, M.E. · Mechanical and Degradation Behaviour, Biomaterials · 2001 · 22 · 883
12. 10.1016/j.actbio.2008.03.00110.1016/j.actbio.2008.03.001 ↗
13. 10.1002/term.8910.1002/term.89 ↗
14. 10.1002/jps.2105910.1002/jps.21059 ↗
15. Tuzlakoglu, K. · Biosci. · 2004 · 4 · 811
16. 10.1016/j.addr.2007.04.02110.1016/j.addr.2007.04.021 ↗
17. 10.1002/adma.20030038010.1002/adma.200300380 ↗
18. 10.1016/0142-9612(96)87284-X10.1016/0142-9612(96)87284-X ↗
19. 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E ↗
20. 10.1016/j.biomaterials.2003.09.04010.1016/j.biomaterials.2003.09.040 ↗
21. 10.22203/eCM.v014a0710.22203/eCM.v014a07 ↗
22. 10.1002/jbm.a.3038510.1002/jbm.a.30385 ↗
23. 10.1002/jbm.b.3060010.1002/jbm.b.30600 ↗
24. 10.1039/b008188o10.1039/b008188o ↗
25. 10.1177/088391150708827410.1177/0883911507088274 ↗
26. 10.1016/S0168-3659(99)00268-010.1016/S0168-3659(99)00268-0 ↗
27. 10.1016/j.biomaterials.2007.12.03110.1016/j.biomaterials.2007.12.031 ↗
28. 10.1089/107632704188771810.1089/1076327041887718 ↗
29. 10.1002/bit.2144610.1002/bit.21446 ↗
30. 10.1073/pnas.050889510310.1073/pnas.0508895103 ↗
31. 10.1016/j.supflu.2007.07.02310.1016/j.supflu.2007.07.023 ↗
32. 10.1016/j.supflu.2006.06.00110.1016/j.supflu.2006.06.001 ↗
33. Reverchon, E. · Eng. Sci. · 2006 · 46 · 188
34. 10.1016/j.polymer.2007.08.02110.1016/j.polymer.2007.08.021 ↗
35. 10.1016/j.memsci.2005.09.04210.1016/j.memsci.2005.09.042 ↗
36. Duarte, A.R.C. · J. Supercrit. Fluids · 2009
37. 10.1016/j.cossms.2003.09.00110.1016/j.cossms.2003.09.001 ↗
38. 10.1201/9780203021378.ch810.1201/9780203021378.ch8 ↗
39. 10.1016/j.eurpolymj.2008.10.00410.1016/j.eurpolymj.2008.10.004 ↗
40. 10.1016/S0142-9612(03)00024-310.1016/S0142-9612(03)00024-3 ↗
41. 10.1016/S0896-8446(03)00044-510.1016/S0896-8446(03)00044-5 ↗
42. 10.1016/j.supflu.2006.09.01110.1016/j.supflu.2006.09.011 ↗
43. Partap, S. · Bulletin · 2007 · 58 · 849
44. 10.1039/B603930H10.1039/B603930H ↗
45. Matthews, M.A. · Device Diagn. Ind. · 2001 · 5 · 140
46. Dillow, A.K. · 2000
47. Kafesjian, R. · 2003
48. Kanno, M. · 2003
49. 10.1016/j.supflu.2005.05.00510.1016/j.supflu.2005.05.005 ↗
50. 10.1016/j.supflu.2007.05.00210.1016/j.supflu.2007.05.002 ↗
51. 10.1021/ja054353f10.1021/ja054353f ↗
52. 10.1021/ja066157u10.1021/ja066157u ↗
53. 10.1016/j.supflu.2008.01.00510.1016/j.supflu.2008.01.005 ↗
54. 10.1016/j.supflu.2008.02.00210.1016/j.supflu.2008.02.002 ↗
55. 10.1016/j.supflu.2005.11.02210.1016/j.supflu.2005.11.022 ↗
56. 10.1016/j.ijpharm.2006.08.02810.1016/j.ijpharm.2006.08.028 ↗